China's AI glasses market takes shape as Xiaomi's entry inspires early adopters
Several users who bought the Xiaomi AI frames when they were released last month found the first-person video recording and AI features useful for documenting personal moments and assisting with office tasks, although there were improvements and missing features they hoped to see in the gadget's future iterations.
The Xiaomi AI glasses were handy for hands-free photography and videography, which was ideal for situations like cycling where the users' hands were occupied, according to a Singapore media industry worker surnamed Li.
'I cycled in the Hutongs when I was in Beijing recently. All I had to do was tell XiaoAI 'start recording', and it conveniently started filming [the ride],' Li told the Post last week.
Xiaomi unveiled its first AI glasses in June, entering a popular but crowded market. Photo: Handout
Pan Yanzhuo, a Beijing-based photographer, said Xiaomi AI's first-person video shooting angle 'offered a unique and fun perspective'. 'I like using it to shoot videos when I'm playing card games,' Pan said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
36 minutes ago
- South China Morning Post
China GDP figures beat market forecasts despite looming US tariff risks
For more on this story: China's economy expanded by 5.2 per cent in the second quarter, keeping it broadly on track to meet this year's growth target. But analysts cautioned that weak domestic demand and rising external uncertainties could provoke a slowdown in the second half of 2025. The closely watched gross domestic product (GDP) figures, released by China's National Bureau of Statistics on July 15, 2025, came in above the 5.17 per cent forecast by a poll of economists from the Chinese financial data provider Wind. The robust headline figures suggest that China's economy has remained resilient in the face of an ongoing trade war with the United States, even as Chinese goods still face an effective US tariff rate of more than 40 per cent, according to Morgan Stanley estimates
South China Morning Post
2 hours ago
- South China Morning Post
‘China's Ozempic' pioneer inks deal with JD Health for online distribution
Innovent Biologics, the first Chinese company to win regulatory approval to sell a GLP-1 drug for weight loss and diabetes, will leverage JD Health's online distribution network as it seeks to grab a slice of a market that could be worth 40 billion yuan (US$5.6 billion) in a decade. The companies will collaborate on supply chain and sales channel development ahead of Innovent's launch of mazdutide, as well as engage in a consumer education campaign. 'Innovent and JD Health will join hands to popularise knowledge about weight loss and blood sugar control via on and offline channels,' Innovent said in a statement posted on its WeChat account on Tuesday. Late last month, eastern Jiangsu province-based Innovent said it received Chinese regulatory approval for mazdutide, which it claimed was the world's first to mimic the natural hormones of GLP-1 and glucagon, with the latter playing a crucial role in regulating blood glucose levels. GLP-1 drugs mimic the actions of the naturally produced hormone glucagon-like peptide-1, which regulates blood sugar levels, suppresses appetite and slows digestion. A woman injects insulin with an insulin pen to treat her diabetes at home. Photo: Shutterstock Images 'Innovent will make its breakthrough dual-target, liver fat-reducing weight loss therapy available to obese patients as soon as possible, to contribute towards the weight management and healthy China initiatives,' said chairman Michael Yu Dechao, without giving a time frame.
South China Morning Post
2 hours ago
- South China Morning Post
Tech war: Nvidia to resume selling H20 graphic processing chips to China in boon for AI
Nvidia said it would sell a made-for-China computer chip to customers in the country, while its founder and CEO Jensen Huang is in Beijing for his third visit this year to the world's second-largest economy amid a deepening and widening rivalry with the US The US government has 'assured Nvidia that licences will be granted' for exporting the H20 chip, a made-for-China product that was less powerful than Nvidia's gold-standard acceleration chip, and the company 'hopes to start deliveries soon', according to a Tuesday statement by the California-based chip designer. Nvidia also planned to release a 'new, fully compliant' RTX PRO graphics processing unit (GPU) for China that was 'ideal for digital twin AI for smart factories and logistics,' the company said. The resumption of sales was a boon for Nvidia as the world's first US$4 trillion company gained access to one of the largest investors in artificial intelligence (AI), where funding could grow 48 per cent this year to US$98 billion , according to a forecast by Bank of America. It is also a breakthrough for China's developers of large language models and other AI uses as they get their hands on some of the most advanced chips for high-powered computing. Image of Nvidia H20 GPU. Photo: Handout Huang, who is expected to attend the International Supply Chain Expo in Beijing tomorrow, met 'government and industry officials to discuss how AI will raise productivity and expand opportunity,' the company said. The expo, a major conference held by the Chinese government, was previously attended by US executives including Apple's Tim Cook. Huang is scheduled to speak in Mandarin tomorrow morning at the Expo, according to a video clip published by the China Council for the Promotion of International Trade (CCPIT), the expo's organiser.
